Navigation Links
New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS

Minneapolis, MN (PRWEB) June 10, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the new Genedata Expressionist for Mass Spectrometry will be showcased at the 61st ASMS Conference on Mass Spectrometry. Compatible with data formats from all major MS vendors, Genedata Expressionist software significantly improves MS lab productivity. It provides an enterprise-level, integrated, and automated data analysis platform, which covers major biopharmaceutical applications including: characterization of post-translational modifications; glycosylation studies; mass analysis of intact proteins; and host cell protein analysis. During ASMS 2013, Genedata will preview the latest version of Genedata Expressionist at the Minneapolis Convention Center (June 10 – 13; Booth #46) and at the Rochester Hospitality Suite at the Hilton Minneapolis Hotel (June 10 – 12; 8pm – 11pm).

Data Processing Time Reduced from Weeks to Hours

Genedata Expressionist for Mass Spectrometry standardizes and automates the analysis of massive mass spectrometry datasets while offering state-of-the-art algorithms for high quality results. “We have implemented Genedata Expressionist for key parts of our workflow in biotherapeutics stability assessment and have successfully removed a major data analysis bottleneck,” noted a senior scientist at Janssen R&D. “What previously took us a month of work, we do now within a day. And Expressionist’s excellent data visualization tools help simplify our decision-making processes.”

“We are excited and encouraged by the market adoption of Genedata Expressionist for Mass Spectrometry, which effectively addresses a data analysis bottleneck for our customers,” said Dr. Othmar Pfannes, CEO of Genedata. “We are committed to advancing Genedata Expressionist as the vendor-agnostic platform of choice for MS data analysis and helping to make key processes in biopharmaceutical R&D as efficient as possible.”

About Genedata:

Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.

Allison Kurz
Marketing & Communications
Phone: +41 61 511 8459

Jackie Thrasivoulos
Public Relations
Phone: +1 508 881 3109


The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Screener to Present at 10th Annual Ion Channel Retreat
2. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
3. Genedata Screener for HCS Advances Phenotypic Screening
4. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
5. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
6. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
10. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
11. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
Post Your Comments:
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... HART ), a biotechnology company developing bioengineered organ implants ... McGorry will present at the LD Micro "Main ... 2:30 p.m. PT. The presentation will be webcast live ... Management will also be available at the conference for ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... ... , ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, ... annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to ... Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the department ...
Breaking Biology Technology:
(Date:11/20/2015)... , November 20, 2015 ... company focused on the growing mobile commerce market and ... Gino Pereira , was recently interviewed on ... will air on this weekend on Bloomberg Europe ... America . --> NXTD ) ("NXT-ID" or ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
Breaking Biology News(10 mins):